SCHEMBL8415358

SCHEMBL8415358

O=[C][C@@H]1CCCN1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124181 1.00
SCHEMBL43081 1.00
SCHEMBL4630631 0.93
SCHEMBL8145993 0.70
SCHEMBL8145989 0.70
SCHEMBL1992557 0.70
SCHEMBL9685848 0.70
SCHEMBL9685846 0.70
SCHEMBL1864942 0.70
SCHEMBL1569910 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196156-A1 ANTI-CORONAVIRUS VACCINES Zoetis Services LLC (US) 2023-06-21 EP claimed
WO-2022035612-A1 ANTI-CORONAVIRUS VACCINES ZOETIS SERVICES LLC (US) 2022-02-17 WO claimed
US-20220047696-A1 ANTI-CORONAVIRUS VACCINES ZOETIS SERVICES LLC 2022-02-17 US claimed
EP-3325015-B1 LIPOSOMAL ADJUVANT COMPOSITIONS ZOETIS SERVICES LLC (US) 2021-05-12 EP claimed
CN-107847603-B Liposome adjuvant composition 硕腾服务有限责任公司 2021-05-11 CN claimed
US-10953080-B2 Oil-based adjuvants ZOETIS SERVICES LLC (US) 2021-03-23 US claimed
US-10456459-B2 Liposomal adjuvant compositions ZOETIS SERVICES LLC (US) 2019-10-29 US claimed
US-20190038737-A1 OIL-BASED ADJUVANTS ZOETIS SERVICES LLC 2019-02-07 US claimed
EP-3325015-A1 LIPOSOMAL ADJUVANT COMPOSITIONS Zoetis Services LLC (US) 2018-05-30 EP claimed
US-20180021424-A1 LIPOSOMAL ADJUVANT COMPOSITIONS ZOETIS SERVICES LLC 2018-01-25 US claimed
EP-0004512-B1 MURAMYL-PEPTIDE ESTER DERIVATIVES AND THEIR APPLICATION TO PHARMACOLOGICAL COMPOSITIONS AND LABORATORY REACTANTS ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1984-01-18 EP claimed
EP-0006068-B1 COMPOUNDS OF THE MURAMYL-PEPTIDE TYPE AND MEDICINES CONTAINING THEM ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1983-09-21 EP claimed
US-4396607-A IMMUNOLOGY, ANTIGENS AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1983-08-02 US claimed
EP-0013856-B1 NEW COMPOUNDS ASSOCIATING PEPTIDYL OR AMINOACYL RESIDUES TO LIPOPHILIC GROUPS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID NEW COMPOUNDS ANVAR Agence Nationale de Valorisation de la Recherche (FR) 1983-03-09 EP claimed
US-4357322-A ADMINISTERING MURAMYL OR DESMETHYLMURAMYL DIPEPTIDES SYNTEX (U.S.A.) INC. (US) 1982-11-02 US claimed
US-4335111-A BACTERICIDES AGENCE NATIONAL DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1982-06-15 US claimed
US-4311699-A Aminoacid derivatives of cephalosporin compounds HASKELL THEODORE H 1982-01-19 US claimed
EP-0015772-A1 N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same WARNER-LAMBERT COMPANY (US) 1980-09-17 EP claimed
EP-0002236-A1 Peptides, their salts, their acid addition salts, pharmaceutical formulations containing them and their use as morphine antagonists and anaesthetics THE WELLCOME FOUNDATION LIMITED (GB) 1979-06-13 EP claimed
US-4082735-A NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF SYNTEX (U.S.A.) INC. (US) 1978-04-04 US claimed